Cart
sales@molnova.com
Casein kinase 1δ-IN-7
CAS No. 764694-25-9
Casein kinase 1δ-IN-7( —— )
Catalog No. M37071 CAS No. 764694-25-9
Casein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 37 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 85 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCasein kinase 1δ-IN-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionCasein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.
-
DescriptionCasein kinase 1δ-IN-7 (compound 497) is a Casein kinase 1δ inhibitor. Casein kinase 1δ-IN-7 can be used in the study of neurodegenerative disorders such as Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCasein Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number764694-25-9
-
Formula Weight338.38
-
Molecular FormulaC17H14N4O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(CC(NC1=CC(C#N)=CC=C1)=O)C2=C3C(SC(C)=C3C)=NC=N2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. InventorJoseph M Sheridan, et al. CASEIN KINASE 1δ (CK1δ) INHIBITORS. Patent WO2012080729A2.
molnova catalog
related products
-
BTX161
BTX161 is a thalidomide analog that mediates degradation of CKIα better than lenalidomide in human AML cells and activates DDR and p53.
-
VU-WS113
VU-WS113 is a potent inhibitor of Wnt signaling with EC50 of 80 nM that selectively potentiates CK1α kinase activity.
-
CK2α-IN-1
CK2α-IN-1 is a selective non-ATP-competitive CK2α inhibitor with an IC50 of 7.0 μM and a Ki of 1.6 μM.CK2α-IN-1 exhibits potential anticancer activity and can be used in cancer research.
